Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Hatch, EE; Herbst, AL; Hoover, RN; Noller, KL; Adam, E; Kaufman, RH; Palmer, JR; Titus-Ernstoff, L; Hyer, M; Hartge, P; Robboy, SJ
   Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States)
   CANCER CAUSES & CONTROL
   
   E.E. Hatch et al., "Incidence of squamous neoplasia of the cervix and vagina in women exposed prenatally to diethylstilbestrol (United States)", CANC CAUSE, 12(9), 2001, pp. 837-845
2. Chatterjee, N; Shih, J; Hartge, P; Brody, L; Tucker, M; Wacholder, S
   Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study
   GENETIC EPIDEMIOLOGY
   
   N. Chatterjee et al., "Association and aggregation analysis using kin-cohort designs with applications to genotype and family history data from the Washington Ashkenazi Study", GENET EPID, 21(2), 2001, pp. 123-138
3. Schildkraut, JM; Cooper, GS; Halabi, S; Calingaert, B; Hartge, P; Whittemore, AS
   Age at natural menopause and the risk of epithelial ovarian cancer
   OBSTETRICS AND GYNECOLOGY
   
   J.M. Schildkraut et al., "Age at natural menopause and the risk of epithelial ovarian cancer", OBSTET GYN, 98(1), 2001, pp. 85-90
4. Modan, B; Hartge, P; Hirsh-Yechezkel, G; Chetrit, A; Lubin, F; Beller, U; Ben-Baruch, G; Fishman, A; Menczer, J; Struewing, JP; Tucker, MA; Wacholder, S; Ebbers, SM; Friedman, E; Piura, B
   Parity, oral contraceptives, and the risk of ovarian cancer among carriersand noncarriers of a BRCA1 or BRCA2 mutation
   NEW ENGLAND JOURNAL OF MEDICINE
   
   B. Modan et al., "Parity, oral contraceptives, and the risk of ovarian cancer among carriersand noncarriers of a BRCA1 or BRCA2 mutation", N ENG J MED, 345(4), 2001, pp. 235-240
5. Titus-Ernstoff, L; Hatch, EE; Hoover, RN; Palmer, J; Greenberg, ER; Ricker, W; Kaufman, R; Noller, K; Herbst, AL; Colton, T; Hartge, P
   Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy
   BRITISH JOURNAL OF CANCER
   
   L. Titus-Ernstoff et al., "Long-term cancer risk in women given diethylstilbestrol (DES) during pregnancy", BR J CANC, 84(1), 2001, pp. 126-133
6. Jemal, A; Devesa, SS; Hartge, P; Tucker, MA
   Recent trends in cutaneous melanoma incidence among whites in the United States
   JOURNAL OF THE NATIONAL CANCER INSTITUTE
   
   A. Jemal et al., "Recent trends in cutaneous melanoma incidence among whites in the United States", J NAT CANC, 93(9), 2001, pp. 678-683
7. Whiteman, DC; Murphy, MFG; Cook, LS; Cramer, DW; Hartge, P; Marchbanks, PA; Nasca, PC; Ness, RB; Purdie, DM; Risch, HA
   Re: Multiple births and risk of epithelial ovarian cancer - Response
   JOURNAL OF THE NATIONAL CANCER INSTITUTE
   
   D.C. Whiteman et al., "Re: Multiple births and risk of epithelial ovarian cancer - Response", J NAT CANC, 93(4), 2001, pp. 319-320
8. Harty, LC; Garcia-Closas, M; Rothman, N; Reid, YA; Tucker, MA; Hartge, P
   Collection of buccal cell DNA using treated cards
   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
   
   L.C. Harty et al., "Collection of buccal cell DNA using treated cards", CANC EPID B, 9(5), 2000, pp. 501-506
9. Baris, D; Kwak, LW; Rothman, N; Wilson, W; Manns, A; Tarone, RE; Hartge, P
   Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients
   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
   
   D. Baris et al., "Blood levels of organochlorines before and after chemotherapy among non-Hodgkin's lymphoma patients", CANC EPID B, 9(2), 2000, pp. 193-197
10. Gnagy, S; Ming, EE; Devesa, SS; Hartge, P; Whittemore, AS
    Declining ovarian cancer rates in US women in relation to parity and oral contraceptive use
    EPIDEMIOLOGY
    
    S. Gnagy et al., "Declining ovarian cancer rates in US women in relation to parity and oral contraceptive use", EPIDEMIOLOG, 11(2), 2000, pp. 102-105
11. Hartge, P
    Hair dyes, cancer, and epidemiology
    CANCER INVESTIGATION
    
    P. Hartge, "Hair dyes, cancer, and epidemiology", CANCER INV, 18(4), 2000, pp. 408-408
12. Hayes, RB; Reding, D; Kopp, W; Subar, AF; Bhat, N; Rothman, N; Caporaso, N; Ziegler, RG; Johnson, CC; Weissfeld, JL; Hoover, RN; Hartge, P; Palace, C; Gohagan, JK
    Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial
    CONTROLLED CLINICAL TRIALS
    
    R.B. Hayes et al., "Etiologic and early marker studies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial", CONTR CL TR, 21(6), 2000, pp. 349S-355S
13. Hartge, P; Hayes, R; Reding, D; Sherman, ME; Prorok, P; Schiffman, M; Buys, S
    Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors - Preliminary data from the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    
    P. Hartge et al., "Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors - Preliminary data from the Prostate, Lung, Colon, and Ovarian Cancer Screening Trial", AM J OBST G, 183(5), 2000, pp. 1232-1237
14. Whiteman, DC; Murphy, MFG; Cook, LS; Cramer, DW; Hartge, P; Marchbanks, PA; Nasca, PC; Ness, RB; Purdie, DM; Risch, HA
    Multiple births and risk of epithelial ovarian cancer
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    D.C. Whiteman et al., "Multiple births and risk of epithelial ovarian cancer", J NAT CANC, 92(14), 2000, pp. 1172-1177
15. Jemal, A; Devesa, SS; Fears, TR; Hartge, P
    Cancer surveillance series: Changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    A. Jemal et al., "Cancer surveillance series: Changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States", J NAT CANC, 92(10), 2000, pp. 811-818
16. Hartge, P
    Raising response rates: Getting to yes
    EPIDEMIOLOGY
    
    P. Hartge, "Raising response rates: Getting to yes", EPIDEMIOLOG, 10(2), 1999, pp. 105-107
17. Sherman, ME; Lee, JS; Burks, RT; Struewing, JP; Kurman, RJ; Hartge, P
    Histopathologic features of ovaries at increased risk for carcinoma - A case-control analysis
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
    
    M.E. Sherman et al., "Histopathologic features of ovaries at increased risk for carcinoma - A case-control analysis", INT J GYN P, 18(2), 1999, pp. 151-157
18. Wacholder, S; Hartge, P
    Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2 - Response
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    S. Wacholder e P. Hartge, "Modeling the probability that Ashkenazi Jewish women carry a founder mutation in BRCA1 or BRCA2 - Response", AM J HU GEN, 65(6), 1999, pp. 1775-1776
19. Hartge, P; Struewing, JP; Wacholder, S; Brody, LC; Tucker, MA
    The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews
    AMERICAN JOURNAL OF HUMAN GENETICS
    
    P. Hartge et al., "The prevalence of common BRCA1 and BRCA2 mutations among Ashkenazi Jews", AM J HU GEN, 64(4), 1999, pp. 963-970
20. Lee, JS; Wacholder, S; Struewing, JP; McAdams, M; Pee, D; Brody, LC; Tucker, MA; Hartge, P
    Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers
    JOURNAL OF THE NATIONAL CANCER INSTITUTE
    
    J.S. Lee et al., "Survival after breast cancer in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers", J NAT CANC, 91(3), 1999, pp. 259-263
21. BLAIR A; HARTGE P; STEWART PA; MCADAMS M; LUBIN J
    MORTALITY AND CANCER INCIDENCE OF AIRCRAFT MAINTENANCE WORKERS EXPOSED TO TRICHLOROETHYLENE AND OTHER ORGANIC-SOLVENTS AND CHEMICALS - EXTENDED FOLLOW-UP
    Occupational and environmental medicine
    
    A. Blair et al., "MORTALITY AND CANCER INCIDENCE OF AIRCRAFT MAINTENANCE WORKERS EXPOSED TO TRICHLOROETHYLENE AND OTHER ORGANIC-SOLVENTS AND CHEMICALS - EXTENDED FOLLOW-UP", Occupational and environmental medicine, 55(3), 1998, pp. 161-171
22. WOODAGE T; KING SM; WACHOLDER S; HARTGE P; STRUEWING JP; MCADAMS M; LAKEN SJ; TUCKER MA; BRODY LC
    THE APC 11307K ALLELE AND CANCER RISK IN A COMMUNITY-BASED STUDY OF ASHKENAZI JEWS
    Nature genetics
    
    T. Woodage et al., "THE APC 11307K ALLELE AND CANCER RISK IN A COMMUNITY-BASED STUDY OF ASHKENAZI JEWS", Nature genetics, 20(1), 1998, pp. 62-65
23. SHERMAN ME; BURKS RT; KURMAN RJ; STRUEWING J; LEE J; HARTGE P
    FINDINGS IN BENIGN OVARIES AT INCREASED RISK FOR DEVELOPING CARCINOMA
    Modern pathology
    
    M.E. Sherman et al., "FINDINGS IN BENIGN OVARIES AT INCREASED RISK FOR DEVELOPING CARCINOMA", Modern pathology, 11(1), 1998, pp. 114-114
24. THORLACIUS S; STRUEWING JP; HARTGE P; OLAFSDOTTIR GH; SIGVALDASON H; TRYGGVADOTTIR L; WACHOLDER S; TULINIUS H; EYFJORD JE
    POPULATION-BASED STUDY OF RISK OF BREAST-CANCER IN CARRIERS OF BRCA2 MUTATION
    Lancet
    
    S. Thorlacius et al., "POPULATION-BASED STUDY OF RISK OF BREAST-CANCER IN CARRIERS OF BRCA2 MUTATION", Lancet, 352(9137), 1998, pp. 1337-1339
25. HATCH EE; PALMER JR; TITUSERNSTOFF L; NOLLER KL; KAUFMAN RH; MITTENDORF R; ROBBOY SJ; HYER M; COWAN CM; ADAM E; COLTON T; HARTGE P; HOOVER RN
    CANCER RISK IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO
    JAMA, the journal of the American Medical Association
    
    E.E. Hatch et al., "CANCER RISK IN WOMEN EXPOSED TO DIETHYLSTILBESTROL IN-UTERO", JAMA, the journal of the American Medical Association, 280(7), 1998, pp. 630-634
26. Colt, JS; Zahm, SH; Camann, DE; Hartge, P
    Comparison of pesticides and other compounds in carpet dust samples collected from used vacuum cleaner bags and from a high-volume surface sampler
    ENVIRONMENTAL HEALTH PERSPECTIVES
    
    J.S. Colt et al., "Comparison of pesticides and other compounds in carpet dust samples collected from used vacuum cleaner bags and from a high-volume surface sampler", ENVIR H PER, 106(11), 1998, pp. 721-724
27. WACHOLDER S; HARTGE P; STRUEWING JP; PEE D; MCADAMS M; BRODY L; TUCKER M
    THE KIN-COHORT STUDY FOR ESTIMATING PENETRANCE
    American journal of epidemiology
    
    S. Wacholder et al., "THE KIN-COHORT STUDY FOR ESTIMATING PENETRANCE", American journal of epidemiology, 148(7), 1998, pp. 623-630
28. TUCKER MA; HARTGE P; HALPERN A; ELDER DE; GERRY D; CLARK WH; HOLLY EA; SAGEBIEL RW
    DIFFERENTIATING DYSPLASTIC NEVI FROM MELANOMA - REPLY
    JAMA, the journal of the American Medical Association
    
    M.A. Tucker et al., "DIFFERENTIATING DYSPLASTIC NEVI FROM MELANOMA - REPLY", JAMA, the journal of the American Medical Association, 278(7), 1997, pp. 548-549
29. TUCKER MA; HALPERN A; HOLLY EA; HARTGE P; ELDER DE; SAGEBIEL RW; GUERRY D; CLARK WH
    CLINICALLY RECOGNIZED DYSPLASTIC NEVI - A CENTRAL RISK FACTOR FOR CUTANEOUS MELANOMA
    JAMA, the journal of the American Medical Association
    
    M.A. Tucker et al., "CLINICALLY RECOGNIZED DYSPLASTIC NEVI - A CENTRAL RISK FACTOR FOR CUTANEOUS MELANOMA", JAMA, the journal of the American Medical Association, 277(18), 1997, pp. 1439-1444
30. STRUEWING JP; HARTGE P; WACHOLDER S; BAKER SM; BERLIN M; MCADAMS M; TIMMERMAN MM; BRODY LC; TUCKER MA
    THE RISK OF CANCER-ASSOCIATED WITH SPECIFIC MUTATIONS OF BRCA1 AND BRCA2 AMONG ASHKENAZI JEWS
    The New England journal of medicine
    
    J.P. Struewing et al., "THE RISK OF CANCER-ASSOCIATED WITH SPECIFIC MUTATIONS OF BRCA1 AND BRCA2 AMONG ASHKENAZI JEWS", The New England journal of medicine, 336(20), 1997, pp. 1401-1408
31. HARTGE P
    ABORTION, BREAST-CANCER, AND EPIDEMIOLOGY
    The New England journal of medicine
    
    P. Hartge, "ABORTION, BREAST-CANCER, AND EPIDEMIOLOGY", The New England journal of medicine, 336(2), 1997, pp. 127-128
32. ZIEGLER RG; COLAVITO EA; HARTGE P; MCADAMS MJ; SCHOENBERG JB; MASON TJ; FRAUMENI JF
    THE IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALS IN THE ETIOLOGY OF LUNG-CANCER
    The FASEB journal
    
    R.G. Ziegler et al., "THE IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALS IN THE ETIOLOGY OF LUNG-CANCER", The FASEB journal, 10(3), 1996, pp. 1385-1385
33. WACHOLDER S; HARTGE P; ARMSTRONG B
    VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY
    American journal of epidemiology
    
    S. Wacholder et al., "VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY", American journal of epidemiology, 143(11), 1996, pp. 1176-1176
34. ZIEGLER RG; COLAVITO EA; HARTGE P; MCADAMS MJ; SCHOENBERG JB; MASON TJ; FRAUMENI JF
    IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALSIN THE ETIOLOGY OF LUNG-CANCER
    Journal of the National Cancer Institute
    
    R.G. Ziegler et al., "IMPORTANCE OF ALPHA-CAROTENE, BETA-CAROTENE, AND OTHER PHYTOCHEMICALSIN THE ETIOLOGY OF LUNG-CANCER", Journal of the National Cancer Institute, 88(9), 1996, pp. 612-615
35. HARTGE P; DEVESA SS; GRAUMAN D; FEARS TR; FRAUMENI JF
    NON-HODGKINS-LYMPHOMA AND SUNLIGHT
    Journal of the National Cancer Institute
    
    P. Hartge et al., "NON-HODGKINS-LYMPHOMA AND SUNLIGHT", Journal of the National Cancer Institute, 88(5), 1996, pp. 298-300
36. COTE TR; MANNS A; HARDY CR; YELLIN FJ; HARTGE P; LEMP G; WEST D; SINGLETON J; YOUNG J; KERNDT P; DEAPEN D; GINZBERG M; ANTONCULVER H; LIEB S; HOPKINS R; WILLIAMS B; LIFF J; MORGAN D; PARKIN W
    EPIDEMIOLOGY OF BRAIN LYMPHOMA AMONG PEOPLE WITH OR WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME
    Journal of the National Cancer Institute
    
    T.R. Cote et al., "EPIDEMIOLOGY OF BRAIN LYMPHOMA AMONG PEOPLE WITH OR WITHOUT ACQUIRED-IMMUNODEFICIENCY-SYNDROME", Journal of the National Cancer Institute, 88(10), 1996, pp. 675-679
37. WACHOLDER S; HARTGE P; LUBIN JH; DOSEMECI M
    NONDIFFERENTIAL MISCLASSIFICATION AND BIAS TOWARDS THE NULL - A CLARIFICATION
    Occupational and environmental medicine
    
    S. Wacholder et al., "NONDIFFERENTIAL MISCLASSIFICATION AND BIAS TOWARDS THE NULL - A CLARIFICATION", Occupational and environmental medicine, 52(8), 1995, pp. 557-558
38. HARTGE P; HOLLY EA; HALPERN A; SAGEBIEL R; GUERRY D; ELDER D; CLARK W; HANSON L; HARRISON C; TARONE R; TUCKER MA
    RECOGNITION AND CLASSIFICATION OF CLINICALLY DYSPLASTIC NEVI FROM PHOTOGRAPHS - A STUDY OF INTEROBSERVER VARIATION
    Cancer epidemiology, biomarkers & prevention
    
    P. Hartge et al., "RECOGNITION AND CLASSIFICATION OF CLINICALLY DYSPLASTIC NEVI FROM PHOTOGRAPHS - A STUDY OF INTEROBSERVER VARIATION", Cancer epidemiology, biomarkers & prevention, 4(1), 1995, pp. 37-40
39. HARTGE P
    RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES - REPLY
    Obstetrics and gynecology
    
    P. Hartge, "RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES - REPLY", Obstetrics and gynecology, 85(2), 1995, pp. 320-320
40. CRAMER DW; HARTGE P; NASCA PC; WHITTEMORE AS
    RISE OF OVARIAN-CANCER AFTER TREATMENT FOR INFERTILITY
    The New England journal of medicine
    
    D.W. Cramer et al., "RISE OF OVARIAN-CANCER AFTER TREATMENT FOR INFERTILITY", The New England journal of medicine, 332(19), 1995, pp. 1302-1302
41. HARTGE P; DEVESA S
    OVARIAN-CANCER, OVULATION AND SIDE OF ORIGIN
    British Journal of Cancer
    
    P. Hartge e S. Devesa, "OVARIAN-CANCER, OVULATION AND SIDE OF ORIGIN", British Journal of Cancer, 71(3), 1995, pp. 642-643
42. WACHOLDER S; HARTGE P; DOSEMECI M; ARMSTRONG B
    VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY
    American journal of epidemiology
    
    S. Wacholder et al., "VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD - REPLY", American journal of epidemiology, 141(3), 1995, pp. 277-277
43. CLEGHORN FR; MANNS A; FALK R; HARTGE P; HANCHARD B; JACK N; WILLIAMS E; JAFFE E; WHITE F; BARTHOLOMEW C; BLATTNER W
    EFFECT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION ON NON-HODGKINS-LYMPHOMA INCIDENCE
    Journal of the National Cancer Institute
    
    F.R. Cleghorn et al., "EFFECT OF HUMAN T-LYMPHOTROPIC VIRUS TYPE-I INFECTION ON NON-HODGKINS-LYMPHOMA INCIDENCE", Journal of the National Cancer Institute, 87(13), 1995, pp. 1009-1014
44. STURGEON SR; HARTGE P; SILVERMAN DT; KANTOR AF; LINEHAN WM; LYNCH C; HOOVER RN
    ASSOCIATIONS BETWEEN BLADDER-CANCER RISK-FACTORS AND TUMOR STAGE AND GRADE AT DIAGNOSIS
    Epidemiology
    
    S.R. Sturgeon et al., "ASSOCIATIONS BETWEEN BLADDER-CANCER RISK-FACTORS AND TUMOR STAGE AND GRADE AT DIAGNOSIS", Epidemiology, 5(2), 1994, pp. 218-225
45. GIUSTI RM; GRACIA F; STEPHENS K; FUKUDA K; VITEK C; HARTGE P; LEVIN A; BLATTNER W; LEVINE P; KAPLAN J
    A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA
    AIDS research and human retroviruses
    
    R.M. Giusti et al., "A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA", AIDS research and human retroviruses, 10(4), 1994, pp. 447-447
46. CLEGHORN F; MANNS A; FALK R; HARTGE P; JAFFE E; HANCHARD B; BARTHOLOMEW C; BLATTNER W
    INCIDENCE OF NON-HODGKINSS LYMPHOMA AND RELATIONSHIP TO HTLV-I EXPOSURE IN JAMAICA AND TRINIDAD
    AIDS research and human retroviruses
    
    F. Cleghorn et al., "INCIDENCE OF NON-HODGKINSS LYMPHOMA AND RELATIONSHIP TO HTLV-I EXPOSURE IN JAMAICA AND TRINIDAD", AIDS research and human retroviruses, 10(4), 1994, pp. 475-475
47. GIUSTI RM; GRACIA F; STEPHENS K; FUKUDA K; VITEK C; HARTGE P; LEVIN A; BLATTNER W; LEVINE P; KAPLAN J
    A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA
    AIDS research and human retroviruses
    
    R.M. Giusti et al., "A SEARCH FOR DISEASES ASSOCIATED WITH HTLV-II AMONG GUAYMI PATIENTS, PANAMA", AIDS research and human retroviruses, 10, 1994, pp. 190000112-190000112
48. HARTGE P; DEVESA SS; FRAUMENI JF
    HODGKINS AND NON-HODGKINS-LYMPHOMAS
    Cancer surveys
    
    P. Hartge et al., "HODGKINS AND NON-HODGKINS-LYMPHOMAS", Cancer surveys, 20, 1994, pp. 423-453
49. HARTGE P; STEWART P
    OCCUPATION AND OVARIAN-CANCER - A CASE-CONTROL STUDY IN THE WASHINGTON, DC, METROPOLITAN-AREA, 1978-1981
    Journal of occupational medicine
    
    P. Hartge e P. Stewart, "OCCUPATION AND OVARIAN-CANCER - A CASE-CONTROL STUDY IN THE WASHINGTON, DC, METROPOLITAN-AREA, 1978-1981", Journal of occupational medicine, 36(8), 1994, pp. 924-927
50. HARTGE P; WHITTEMORE AS; ITNYRE J; MCGOWAN L; CRAMER D; CASAGRANDE JT; KELSEY JL; LEE M; LEE NC; LYON JL; MARSHALL JR; NASCA PC; PAFFENBARGER RS; ROSENBERG L; WEISS NS
    RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES
    Obstetrics and gynecology
    
    P. Hartge et al., "RATES AND RISKS OF OVARIAN-CANCER IN SUBGROUPS OF WHITE WOMEN IN THE UNITED-STATES", Obstetrics and gynecology, 84(5), 1994, pp. 760-764
51. WACHOLDER S; BENICHOU J; HEINEMAN EF; HARTGE P; HOOVER RN
    ATTRIBUTABLE RISK - ADVANTAGES OF A BROAD DEFINITION OF EXPOSURE
    American journal of epidemiology
    
    S. Wacholder et al., "ATTRIBUTABLE RISK - ADVANTAGES OF A BROAD DEFINITION OF EXPOSURE", American journal of epidemiology, 140(4), 1994, pp. 303-309
52. HORN EP; HARTGE P; SHIELDS JA; TUCKER MA
    SUNLIGHT AND RISK OF UVEAL MELANOMA
    Journal of the National Cancer Institute
    
    E.P. Horn et al., "SUNLIGHT AND RISK OF UVEAL MELANOMA", Journal of the National Cancer Institute, 86(19), 1994, pp. 1476-1478
53. HARTGE P; SILVERMAN DT; SCHAIRER C; HOOVER RN
    SMOKING AND BLADDER-CANCER RISK IN BLACKS AND WHITES IN THE UNITED-STATES
    CCC. Cancer causes & control
    
    P. Hartge et al., "SMOKING AND BLADDER-CANCER RISK IN BLACKS AND WHITES IN THE UNITED-STATES", CCC. Cancer causes & control, 4(4), 1993, pp. 391-394
54. DORGAN JF; ZIEGLER RG; SCHOENBERG JB; HARTGE P; MCADAMS MJ; FALK RT; WILCOX HB; SHAW GL
    RACE AND SEX-DIFFERENCES IN ASSOCIATIONS OF VEGETABLES, FRUITS, AND CAROTENOIDS WITH LUNG-CANCER RISK IN NEW-JERSEY (UNITED-STATES)
    CCC. Cancer causes & control
    
    J.F. Dorgan et al., "RACE AND SEX-DIFFERENCES IN ASSOCIATIONS OF VEGETABLES, FRUITS, AND CAROTENOIDS WITH LUNG-CANCER RISK IN NEW-JERSEY (UNITED-STATES)", CCC. Cancer causes & control, 4(3), 1993, pp. 273-281
55. MANNS A; CLEGHORN FR; FALK R; HANCHARD B; JAFFE ES; BARTHOLOMEW C; HARTGE P; BENICHOU J; BLATTNER WA
    ROLE OF HTLV-I IN DEVELOPMENT OF NON-HODGKIN-LYMPHOMA IN JAMAICA AND TRINIDAD-AND-TOBAGO
    Lancet
    
    A. Manns et al., "ROLE OF HTLV-I IN DEVELOPMENT OF NON-HODGKIN-LYMPHOMA IN JAMAICA AND TRINIDAD-AND-TOBAGO", Lancet, 342(8885), 1993, pp. 1447-1450
56. WACHOLDER S; ARMSTRONG B; HARTGE P
    VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD
    American journal of epidemiology
    
    S. Wacholder et al., "VALIDATION STUDIES USING AN ALLOYED GOLD STANDARD", American journal of epidemiology, 137(11), 1993, pp. 1251-1258